BOSTON SCIENTIFIC CORP — Director's Dealing 2023

Feb 6, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2023-02-03

Reporting Person: Butcher Arthur C (EVP& Grp Pres, MedSurg & APAC)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-03	Common Stock	M	10822.0000	$16.3100	Acquired	46180.0000	Direct
2023-02-03	Common Stock	M	4212.0000	$17.2600	Acquired	50392.0000	Direct
2023-02-03	Common Stock	S	27000.0000	$48.7421	Disposed	23392.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-02-03	Stock Option (Right to Buy)	$17.2600	M	4212.0000	Disposed	2026-02-22	Common Stock (4212.0000)	Direct
2023-02-03	Stock Option (Right to Buy)	$16.3100	M	10822.0000	Disposed	2025-02-23	Common Stock (10822.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2545.0000	Indirect

Footnotes

F1: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $48.70 to $48.78, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2: Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.

F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

F4: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.